- Stay Connected
Coronado Biosciences Debuts on Nasdaq, Moves Two Lead Drugs Forward – Xconomy
|
Coronado Biosciences Debuts on Nasdaq, Moves Two Lead Drugs Forward
Xconomy The path to becoming a publicly listed company chosen by Coronado Biosciences (NASDAQ: CNDO) was anything but conventional, but it seems to be working for the biotech startup. After raising $ 47.4 million privately over the last year, the company filed … Coronado Biosciences Approved for Listing on NASDAQ (CNDO) Coronado Biosciences to Begin Trading on NASDAQ Today |
